Deficiency of interleukin-1 receptor antagonist
Active Research Protocols
- 03-AR-0173 – Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)
- 13-AR-0086 – A Pilot Open-Label Study of Rilonacept (Arcalyst) in the Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
- 94-HG-0105 – Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014